Plasminogen activator of clonogenic cell populations separated from fibrosarcoma (original) (raw)

Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator

Justin McCormick

Cancer Research, 1991

View PDFchevron_right

Jankun J, Maher VM, McCormick JJMalignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator. Cancer Res 51: 1221-1226

Jerzy Jankun

Cancer Research

View PDFchevron_right

Die Bedeutung von Tumorsuppressorgenen in der Tumortherapie

Brigitte Pützer

TumorDiagnostik & Therapie, 2000

View PDFchevron_right

Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice

Tullio Giraldi

Clinical & Experimental Metastasis, 1987

View PDFchevron_right

Suppression of Tumor Cell Growth in Vitro by a Bone Marrow Factor1

Michael Bennett

View PDFchevron_right

Poliglikolik Asit ve Polilaktid Ko-Glikolid Asitlerinin Tümörijenik ve Non-Tümörijenik Matür Sferoidlerde İn Vitro Biyouyumluluğunun Değerlendirilmesi ve Karşılaştırılması

Prof. Dr. Mine Ergüven

Turkiye Klinikleri Journal of Medical Sciences, 2011

View PDFchevron_right

Effect of L-Arginine and L-NAME treatments on polymorphonuclear leukocytes and mononuclear cells influx during tumor growth 1 Efeito dos tratamentos com L-Arginina e L-NAME sobre o influxo de leucócitos polimorfonucleares e células mononucleares durante o desenvolvimento tumoral

silvana coradi

2009

View PDFchevron_right

A non-clonogenic assay for the determination of the sensitivity of leukemic cells to chemotherapeutic agents

Joshua Epstein

European journal of cancer & clinical oncology, 1983

View PDFchevron_right

Malignant myeloblastic transformation of murine long-term bone marrow cultures by F-MuLV:In vitro reproduction of a long-term leukemogenesis, and investigation of preleukemic events

Brigitte Sola

International Journal of Cancer, 1983

View PDFchevron_right

Human Leukemia and Lympnoma Cells1

Mervyn Israel

View PDFchevron_right

Hematopoietic and therapeutic properties of bestatin in normal and myelosuppressed mice

James E Talmadge

Biomedicine Pharmacotherapy, 1991

View PDFchevron_right

Clonogenic potential of myeloid leukaemia cells in vitro is restricted to leukaemia cells expressing the CD34 antigen

Venu Gopal

European Journal of Cancer, 1993

View PDFchevron_right

520. Zoucas E et al Cancer Res 1986,46,5662-5666

Stig Bengmark

View PDFchevron_right

Cytologic Studies of Tumors. LI

Yoshitaka Obara

Proceedings of the Japan Academy

View PDFchevron_right

Studies of an Implanted Murine Myelogenous Leukemia C14981

Carol McMahon

2000

View PDFchevron_right

The development of in vitro and in vivo anti-tumor cytotoxicity in noncytotoxic, MOPC-315-tumor-bearer, spleen cells ?educated? in vitro with MOPC-315 tumor cells

Donald Braun

Cancer Immunology Immunotherapy, 1978

View PDFchevron_right

Studies of lymphocyte stimulation to tumor-associated antigen

Rishab Gupta

Cancer Immunology Immunotherapy, 1979

View PDFchevron_right

Studies of an Implanted Murine Myelogenous Leukemia C1498

Carol McMahon

The Ohio journal of science

View PDFchevron_right

Increased chemotaxis of leukocytes from mice bearing tumors

Helen Ratajczak

Cancer research, 1986

View PDFchevron_right

Effect of chemotherapeutic agents and hormones on organ cultures of human tumours

Ruy Tchao

European journal of cancer, 1968

View PDFchevron_right

Correlation of proliferative and clonogenic tumor cells in multiple myeloma

Judith Karp

Cancer Research

View PDFchevron_right

Factors modifying the growth of several transplantable tumors

Leonard Inker

1959

View PDFchevron_right

Terapia mirata alle cellule staminali tumorali altamente resistenti alle terapie convenzionali

Premio Sapio

View PDFchevron_right

Antigenic modifications associated with “spontaneous” malignant alterations of mouse fibroblasts propagated in vitro

Berthe Willumsen

Carlsberg Research Communications, 1984

View PDFchevron_right

Cell cooperation in abolition of tolerance to xenogeneic tumor

Filip Culo

Cellular Immunology, 1976

View PDFchevron_right

A comparison of three in vivo assays for cell tumorigenicity

John Petricciani

PubMed, 1974

View PDFchevron_right

Cis-diamminedichloroplatinum sensitivity of murine reticulum sarcoma cells in primary culture and after in vitro passages

Maurizio D'Incalci

In Vitro Cellular & Developmental Biology - Animal, 1993

View PDFchevron_right

986;46:5662-5666. Cancer Res Colon Carcinoma in the Rat Hemostasis following Inoculation and during Spreading of Updated version Hemostasis following Inoculation and during Spreading of Colon Carcinoma in the Rat1

Stig Bengmark

View PDFchevron_right

Plasminogen activation in human leukemia and in normal hematopoietic cells

Ross Stephens

APMIS, 1999

View PDFchevron_right

Enhancement of drug cytotoxicity by recruitment of leukemic myeloblasts with humoral stimulation

Judith Karp

Cancer Research

View PDFchevron_right

Relationship between circulating plasminogen activators and tumor development in mice

Marina Colombi

Cancer research, 1986

View PDFchevron_right

Plasminogen activator activity in differentiating leukemia cells

Eitan Fibach

FEBS Letters, 1984

View PDFchevron_right

Relationship between multiple from of plasminogen activater in human breast tumors and plasma and the presence of metastases in lymph nodes

Marina Colombi

Cancer Research

View PDFchevron_right

Treatment with the anti-tumor drugs, cis-platin and mafosfamide, does not affect the structure of prekinetochores in a human breast cancer cell line. An immunofluorescence study using human anticentromere autoantibodies

Andres Zuniga Mendoza

Annals of Anatomy - Anatomischer Anzeiger, 1996

View PDFchevron_right